FIL Ltd - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 72 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
FIL Ltd ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2018$47,156,000
+583.6%
742,848
+330.6%
0.07%
+273.7%
Q1 2017$6,898,000
-4.3%
172,497
-32.9%
0.02%
-9.5%
Q4 2016$7,209,000
-61.4%
256,997
-59.1%
0.02%
-62.5%
Q3 2016$18,683,000
+14.8%
629,064
-21.7%
0.06%
+7.7%
Q2 2016$16,272,000
+12.2%
803,5590.0%0.05%
+15.6%
Q1 2016$14,504,000
-31.5%
803,5590.0%0.04%
-29.7%
Q4 2015$21,166,000803,5590.06%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders